Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Breast Cancer

Free Subscription 20.06.2022 1 Ann Surg 2 Ann Surg Oncol 1 BMC Cancer 1 Breast Cancer Res 4 Breast Cancer Res Treat 1 Cancer Cell 1 Clin Breast Cancer 1 Eur J Cancer 1 Eur Radiol 1 Int J Oncol 1 J Clin Oncol 2 J Natl Cancer Inst 2 J Surg Oncol 1 JAMA 2 N Engl J Med 3 NPJ Breast Cancer 1 Oncogene 1 Radiology 1 Semin Oncol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Surg

1. HUNT KK
   Editorial on Toesca A, et al "A Randomized Trial of Robotic Mastectomy versus Open Surgery in Women With Breast Cancer or BRCA Mutation".
   Ann Surg. 2022 May 13. pii: 00000658-990000000-00003.
   PubMed        
   
   

   
   Ann Surg Oncol

2. CHEN JC, Bazan JG, Obeng-Gyasi S
   ASO Author Reflections: Surgical Management Should be Considered in Patients with De Novo Stage IV Inflammatory Breast Cancer.
   Ann Surg Oncol. 2022 Jun 14. pii: 10.1245/s10434-022-12016.
   PubMed        
   
   
3. TINTERRI C, Gentile D, Gatzemeier W, Sagona A, et al
   ASO Visual Abstract: Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1-2 Breast Cancer Patients Presenting 1-2 Metastatic Sentinel Lymph Nodes: The Multicenter Randomized Clinical Trial SINODAR-ONE.
   Ann Surg Oncol. 2022 Jun 12. pii: 10.1245/s10434-022-11908.
   PubMed        
   
   

   
   BMC Cancer

4. SEHOVIC E, Urru S, Chiorino G, Doebler P, et al
   Meta-analysis of diagnostic cell-free circulating microRNAs for breast cancer detection.
   BMC Cancer. 2022;22:634.
   PubMed         Abstract available
   
   

   
   Breast Cancer Res

5. CARR D, Zein A, Coulombe J, Jiang T, et al
   Multiple roles for Bcl-3 in mammary gland branching, stromal collagen invasion, involution and tumor pathology.
   Breast Cancer Res. 2022;24:40.
   PubMed         Abstract available
   
   

   
   Breast Cancer Res Treat

6. CORKE L, Luzhna L, Willemsma K, Illmann C, et al
   Clinical utility of MRI in the neoadjuvant management of early-stage breast cancer.
   Breast Cancer Res Treat. 2022 Jun 15. pii: 10.1007/s10549-022-06640.
   PubMed         Abstract available
   
   
7. JU J, Du F, Gao SL, Si YR, et al
   Combined analysis of receptor expression reflects inter-and intra-tumor heterogeneity in HR+/HER2+ breast cancer.
   Breast Cancer Res Treat. 2022 Jun 14. pii: 10.1007/s10549-022-06629.
   PubMed         Abstract available
   
   
8. WELLERDIECK NEA, Wessels P, Los M, Sonke GS, et al
   Local and systemic therapy in breast cancer patients with central nervous system metastases.
   Breast Cancer Res Treat. 2022 Jun 9. pii: 10.1007/s10549-022-06605.
   PubMed         Abstract available
   
   
9. LAZZARO C
   Lazzaro responds to Pouwels et al.
   Breast Cancer Res Treat. 2021;190:1.
   PubMed        
   
   

   
   Cancer Cell

10. DENKERT C, Loibl S
    Response-based molecular subtyping-emergence of the third generation of breast cancer subtypes.
    Cancer Cell. 2022;40:592-594.
    PubMed         Abstract available
    
    

    
    Clin Breast Cancer

11. MALLA R, Puvalachetty K, Vempati RK, Marni R, et al
    Cancer Stem Cells and Circulatory Tumor Cells Promote Breast Cancer Metastasis.
    Clin Breast Cancer. 2022 May 19. pii: S1526-8209(22)00094.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

12. ALTUNDAG K
    Re: Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study: Higher visceral tumour burden and weak estrogen rece
    Eur J Cancer. 2022;171:43.
    PubMed        
    
    

    
    Eur Radiol

13. XU Z, Ding Y, Zhao K, Han C, et al
    MRI characteristics of breast edema for assessing axillary lymph node burden in early-stage breast cancer: a retrospective bicentric study.
    Eur Radiol. 2022 Jun 15. pii: 10.1007/s00330-022-08896.
    PubMed         Abstract available
    
    

    
    Int J Oncol

14. DONG H, Wang W, Chen R, Zhang Y, et al
    [Retracted] Exosome-mediated transfer of lncRNASNHG14 promotes trastuzumab chemoresistance in breast cancer.
    Int J Oncol. 2022;61.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

15. REDING KW, Cheng RK, Barac A, Vasbinder A, et al
    Toward a Better Understanding of the Differential Impact of Heart Failure Phenotypes After Breast Cancer.
    J Clin Oncol. 2022 Jun 10:JCO2200111. doi: 10.1200/JCO.22.00111.
    PubMed        
    
    

    
    J Natl Cancer Inst

16. KEATING NL, Brooks GA, Landrum MB, Liu PH, et al
    The Oncology Care Model and Adherence to Oral Cancer Drugs: A Difference-in-Differences Analysis.
    J Natl Cancer Inst. 2022;114:871-877.
    PubMed         Abstract available
    
    
17. MOSS JL, Pinto CN, Srinivasan S, Cronin KA, et al
    Enduring Cancer Disparities by Persistent Poverty, Rurality, and Race: 1990-1992 to 2014-2018.
    J Natl Cancer Inst. 2022;114:829-836.
    PubMed         Abstract available
    
    

    
    J Surg Oncol

18. DA COSTA VIEIRA RA, Andrade WP, Vieira SC, Romano M, et al
    Surgical management of locally advanced breast cancer: Recommendations of the Brazilian Society of Surgical Oncology.
    J Surg Oncol. 2022;126:57-67.
    PubMed         Abstract available
    
    
19. CARNEIRO VCG, Gifoni ACLVC, Mauro Rossi B, Andrade CEMDC, et al
    Cancer risk-reducing surgery: Brazilian society of surgical oncology guideline part 1 (gynecology and breast).
    J Surg Oncol. 2022;126:10-19.
    PubMed         Abstract available
    
    

    
    JAMA

20. KERLIKOWSKE K, Su YR, Sprague BL, Tosteson ANA, et al
    Association of Screening With Digital Breast Tomosynthesis vs Digital Mammography With Risk of Interval Invasive and Advanced Breast Cancer.
    JAMA. 2022;327:2220-2230.
    PubMed         Abstract available
    
    

    
    N Engl J Med

21. CORTES J, Im SA, Cathcart J
    Trastuzumab Deruxtecan for Breast Cancer. Reply.
    N Engl J Med. 2022;386:2347.
    PubMed        
    
    
22. ZHENG F, Du F, Yuan P
    Trastuzumab Deruxtecan for Breast Cancer.
    N Engl J Med. 2022;386:2346-2347.
    PubMed        
    
    

    
    NPJ Breast Cancer

23. CAREY LA, Loirat D, Punie K, Bardia A, et al
    Sacituzumab govitecan as second-line treatment for metastatic triple-negative breast cancer-phase 3 ASCENT study subanalysis.
    NPJ Breast Cancer. 2022;8:72.
    PubMed         Abstract available
    
    
24. AL ABO M, Gearhart-Serna L, Van Laere S, Freedman JA, et al
    Adaptive stress response genes associated with breast cancer subtypes and survival outcomes reveal race-related differences.
    NPJ Breast Cancer. 2022;8:73.
    PubMed         Abstract available
    
    
25. HURSON AN, Abubakar M, Hamilton AM, Conway K, et al
    Prognostic significance of RNA-based TP53 pathway function among estrogen receptor positive and negative breast cancer cases.
    NPJ Breast Cancer. 2022;8:74.
    PubMed         Abstract available
    
    

    
    Oncogene

26. RONG Z, Zhang L, Li Z, Xiao Z, et al
    Correction: SIK2 maintains breast cancer stemness by phosphorylating LRP6 and activating Wnt/beta-catenin signaling.
    Oncogene. 2022 Jun 14. pii: 10.1038/s41388-022-02374.
    PubMed        
    
    

    
    Radiology

27. KIM SY, Cho N, Hong H, Lee Y, et al
    Abbreviated Screening MRI for Women with a History of Breast Cancer: Comparison with Full-Protocol Breast MRI.
    Radiology. 2022 Jun 14:213310. doi: 10.1148/radiol.213310.
    PubMed         Abstract available
    
    

    
    Semin Oncol

28. BHANGOO RS, Cheng TW, Petersen MM, Thorpe CS, et al
    Radiation recall dermatitis: A review of the literature.
    Semin Oncol. 2022;49:152-159.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: